سعر روكسونين 60مجم 20 قرص 2023

Loxoprofen 60 mg tablets, 20 tablets (2 strips); made by SAJA Pharmaceuticals (Saudi Arabia), listed in Egypt with Genuine Pharma. Brand ROXONIN (under licence from Daiichi Sankyo).

• Relief of inflammation and pain in rheumatoid arthritis, osteoarthritis, low back pain, periarthritis of the shoulder, shoulder-arm-neck syndrome and toothache.Population: AdultsSaja Pharma (Saudi Arabian Japanese Pharmaceutical Co.)
• Relief of pain and inflammation after surgery, trauma or tooth extraction.Population: AdultsSaja Pharma (Saudi Arabian Japanese Pharmaceutical Co.)
• Antipyresis and pain relief in acute upper respiratory tract inflammation (including when accompanying acute bronchitis).Population: AdultsSaja Pharma (Saudi Arabian Japanese Pharmaceutical Co.)

• Adverse reactions were reported in 3.03% of 13,486 patients, mainly gastrointestinal symptoms (stomach discomfort, abdominal pain, nausea/vomiting, anorexia: 2.25%), oedema (0.59%), rash/urticaria (0.21%) and sleepiness (0.10%).International label, same formulation · Saja Pharma (Saudi Arabian Japanese Pharmaceutical Co.)
• Clinically significant reactions (incidence unknown): shock/anaphylactoid reactions, haemolytic anaemia, leukopenia, thrombocytopenia, Stevens-Johnson syndrome, toxic epidermal necrolysis, acute renal failure, nephrotic syndrome, interstitial nephritis, congestive heart failure, interstitial pneumonia, gastrointestinal bleeding or perforation, hepatic dysfunction/jaundice, asthma attacks and aseptic meningitis; discontinue if they occur.International label, same formulation · Saja Pharma (Saudi Arabian Japanese Pharmaceutical Co.)

• Peptic ulcer.International label, same formulation · Saja Pharma (Saudi Arabian Japanese Pharmaceutical Co.)
• Severe blood disorders, severe hepatic dysfunction, severe renal impairment or severe cardiac failure.International label, same formulation · Saja Pharma (Saudi Arabian Japanese Pharmaceutical Co.)
• History of hypersensitivity to any ingredient of the product.International label, same formulation · Saja Pharma (Saudi Arabian Japanese Pharmaceutical Co.)

• Use with caution in patients with a history of peptic ulcer, blood, hepatic or renal disorders, cardiac dysfunction, hypersensitivity, bronchial asthma, ulcerative colitis, Crohn's disease, and in the elderly.International label, same formulation · Saja Pharma (Saudi Arabian Japanese Pharmaceutical Co.)
• Treatment is symptomatic, not causal; avoid long-term use of the same drug in acute conditions, avoid concomitant use with other anti-inflammatory analgesics, and note that loxoprofen may mask signs of infection.International label, same formulation · Saja Pharma (Saudi Arabian Japanese Pharmaceutical Co.)
• Excessive fall in body temperature, collapse and cold extremities may occur, especially in elderly patients with high fever or debilitated patients; monitor closely.International label, same formulation · Saja Pharma (Saudi Arabian Japanese Pharmaceutical Co.)

• Coumarin anticoagulants (e.g. warfarin)Anticoagulant effect may be enhanced; use caution and reduce the dose as necessary.Saja Pharma (Saudi Arabian Japanese Pharmaceutical Co.)
• Sulfonylurea hypoglycaemic agents (e.g. tolbutamide)Hypoglycaemic effect may be enhanced; use caution and reduce the dose as necessary.Saja Pharma (Saudi Arabian Japanese Pharmaceutical Co.)
• New quinolone antibacterials (e.g. enoxacin)Convulsant effect of the quinolone may be enhanced.Saja Pharma (Saudi Arabian Japanese Pharmaceutical Co.)

• Use in women who are or may be pregnant only if the expected therapeutic benefit outweighs any potential risk; safety in pregnancy has not been established.International label, same formulation · Saja Pharma (Saudi Arabian Japanese Pharmaceutical Co.)
• Avoid in nursing mothers; if treatment is essential, breastfeeding should be discontinued (loxoprofen is excreted in rat milk).International label, same formulation · Saja Pharma (Saudi Arabian Japanese Pharmaceutical Co.)

• Loxoprofen: Prodrug absorbed unchanged and rapidly converted to its active trans-OH metabolite, which inhibits prostaglandin biosynthesis at cyclo-oxygenase (Saudi ROXONIN SmPC).